In focus
Latest feed
Pfizer Shares Slip After Seagen’s Origin Cancer Drug Delivers Mixed Top‑line Results
Closing Bell Insights: Navigating Pfizer, Agribusiness, and Gold Miners as the Market Winds Down
Unpacking the Market's Best Bets: Four 'Final Trades' Worth Your Attention
Olema Pharmaceuticals Stock Takes a Dive: What Sparked the Sudden Plunge?